Добірка наукової літератури з теми "Osteoporosic fractures"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Osteoporosic fractures".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Osteoporosic fractures"
Baccichetti, A., P. L. Nguyen-Thi, A. Blum, D. Mainard, F. Sirveaux, L. Nace, A. Valance, et al. "SAT0459 EVALUATION OF THE PREVALENCE AND THE MANAGEMENT OF OSTEOPOROTIC FRACTURES IN PATIENTS HOSPITALIZED AT NANCY UNIVERSITY HOSPITAL (FRANCE) IN 2017." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1187.1–1187. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3366.
Повний текст джерелаMurillo, Bernardo, Christian Antonio Allende Nores, and Orlando Rodríguez. "Incidencia de diagnóstico y tratamiento de la osteoporosis en pacientes con fractura de radio distal. [Diagnosis and treatment incidence of osteoporosis in patients with distal radius fractures]." Revista de la Asociación Argentina de Ortopedia y Traumatología 84, no. 2 (May 2, 2019): 99–104. http://dx.doi.org/10.15417/issn.1852-7434.2019.84.2.664.
Повний текст джерелаLyalina, V. V., I. A. Borshenko, S. V. Borisovskaya, E. A. Skripnichenko, R. V. Binyakovskiy, V. V. Trishina, and I. G. Nikitin. "Acute Osteoporotic Vertebral Fracture. Part 1. Definitions, Clinical Presentation, Pain Assessment, Diagnostic Imaging, Introduction to Differential Diagnosis." Russian Archives of Internal Medicine 12, no. 4 (July 30, 2022): 254–66. http://dx.doi.org/10.20514/2226-6704-2022-12-4-254-266.
Повний текст джерелаLyalina, V. V., I. A. Borshenko, S. V. Borisovskaya, E. A. Skripnichenko, R. V. Binyakovskiy, V. D. Solomin, V. V. Trishina, and I. G. Nikitin. "Acute Osteoporotic Vertebral Fracture. Part 2. Differential Diagnostics According to the Data of Imaging Methods. Conservative and Surgical Treatment." Russian Archives of Internal Medicine 12, no. 6 (November 29, 2022): 438–49. http://dx.doi.org/10.20514/2226-6704-2022-12-6-438-449.
Повний текст джерелаLaffaire, M., M. Caroline, E. Allado, E. Bauer, I. Chary Valckenaere, and D. Loeuille. "AB0948 Osteoporotic screening and prevalence of severe osteoporotic fractures in a population of psoriatic arthritis initiating a biologic treatment." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1602.2–1603. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3871.
Повний текст джерелаAhn, Seong Hee, Seongbin Hong, Young J. Suh, Da Hea Seo, Yujin Jeong, Yongin Cho, and So Hun Kim. "ODP087 Dose-dependent effect of long-term statin use on risk of osteoporotic fracture in elderly patients." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A162. http://dx.doi.org/10.1210/jendso/bvac150.331.
Повний текст джерелаDionyssiotis, Yannis, Grigorios Skarantavos, and Panayiotis Papagelopoulos. "Modern Rehabilitation in Osteoporosis, Falls, and Fractures." Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 7 (January 2014): CMAMD.S14077. http://dx.doi.org/10.4137/cmamd.s14077.
Повний текст джерелаKerschan-Schindl, K., M. Hackl, E. Boschitsch, U. Föger-Samwald, O. Nägele, S. Skalicky, M. Weigl, J. Grillari, and P. Pietschmann. "Diagnostic Performance of a Panel of miRNAs (OsteomiR) for Osteoporosis in a Cohort of Postmenopausal Women." Calcified Tissue International 108, no. 6 (January 11, 2021): 725–37. http://dx.doi.org/10.1007/s00223-020-00802-3.
Повний текст джерелаBelova, K. Yu, O. B. Yershova, A. A. Degtyarev, M. V. Belov, V. O. Gerasimov, and S. Yu Fedotov. "REFRACTURE PREVENTION SYSTEM: FIRST RESULTS OF A PILOT PROGRAM WITHIN THE PROJECT «PROMETHEUS» IN YAROSLAVL." Osteoporosis and Bone Diseases 17, no. 2 (December 15, 2014): 3–6. http://dx.doi.org/10.14341/osteo201423-6.
Повний текст джерелаTile, Lianne, and Angela M. Cheung. "Atypical femur fractures: current understanding and approach to management." Therapeutic Advances in Musculoskeletal Disease 12 (January 2020): 1759720X2091698. http://dx.doi.org/10.1177/1759720x20916983.
Повний текст джерелаДисертації з теми "Osteoporosic fractures"
Kaptoge, Stephen Kipkemoi. "Epidemiology of risk factors for osteoporosis and osteoporotic fractures." Thesis, University of Cambridge, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.615203.
Повний текст джерелаBraz, Manuela Giuliani Marcondes Rocha. "Sequenciamento paralelo em larga escala de genes candidatos para fragilidade óssea em indivíduos com osteoporose grave, familiar ou idiopática." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5135/tde-22102018-123623/.
Повний текст джерелаOsteoporosis is a highly prevalent disorder resulting in fragility fractures and incurring in great morbi-mortality and economic burden. In most cases, osteoporosis has a multifactorial etiology, with an estimated heritability of 50-85% attributable to a combination of several low-impact genetic variants. Rarely, cases of syndromic osteoporosis due to high-impact genetic defects are seen. It is therefore hypothesized that severe/idiopathic cases of otherwise inconspicuous osteoporosis may have a monoor oligogenic etiology due to genetic variants with an intermediate effect. During the past years, advances in molecular sequencing have revealed novel candidate genes for bone fragility, and have enabled simultaneous sequencing of multiple genes. In this context, the objectives of this research project were: 1) to identify candidate genes for bone fragility, as previously reported in association to Mendelian disorders with high impact on bone resistance, idiopathic or familial osteoporosis, and genome-wide association studies (GWAS) for bone mineral density and fragility fractures; and 2) to perform molecular analysis of these candidate genes in patients with severe, familial or idiopathic osteoporosis. Through a systematic review, 128 candidate genes were identified and included in a panel for massively parallel sequencing. Coding regions and 25-bp boundaries were captured and sequenced. Rare variants (allele frequency < 1%), with a predicted high impact on protein function were initially selected as variants of interest. Thirty-seven subjects (21 sporadic cases and 7 families) were included according to stringent criteria based on clinical and densitometric evaluation, excluding individuals with secondary osteoporosis. Males represented 54% of the cohort, median age at diagnosis was 44 years, and 84% of subjects had a history of fractures. Thirtythree variants of interest were identified initially. After familial segregation analysis, 5 variants were considered as benign in regard to bone fragility, resulting in 28 potentially pathogenic variants, all heterozygous, present in 71% of the cohort. Of these variants, 26 were nonsynonymous, there was one 9-bp deletion and one large deletion involving the only coding exon of candidate gene GPR68. An association of two or more variants in different genes was present in 21% of the cohort, including a young woman with severe osteoporosis and variants in WNT1, PLS3 and NOTCH2. Familial segregation in this case suggested an additive pathogenic effect of these variants. Twenty-five percent of potentially pathogenic variants were identified in well-established candidate genes (WNT1, PLS3, COL1A1, COL1A2), and 57% located to novel candidate genes initially identified by GWAS, such as NBR1 and GPR68, which have been previously associated to changes in bone remodeling in mouse models. These results support the involvement of GWAS genes in the pathophysyiology of osteoporosis, and indicate a prominent role for digenic/oligogenic interactions in cases of severe, familial or idiopathic osteoporosis. Recognition of new molecular pathways in the determination of bone fragility may lead to the development of new drugs, and the identification of pathogenic variants associated to osteoporosis may allow individualized clinical management of patients and their relatives
Ugarte, Corbalán Laura de 1988. "The regulatory roles of MicroRNAs in bone remodeling and osteoporosis." Doctoral thesis, Universitat Pompeu Fabra, 2016. http://hdl.handle.net/10803/565403.
Повний текст джерелаEn l’àmbit de l’estudi de l’òs, els microRNAs (miRNAs) han estat descrits com factors claus en la regulació de la formació, remodelatge i homeòstasis de l’ òs. La identificació de miRNAs implicats en la funció esquelètica és imprescindible pel desenvolupament de noves estratègies terapèutiques, basades en miRNAs, dirigides al tractament de malalties òssies. Com en el cas d’altres molècules reguladores, els miRNAs poden patir modificacions durant el desenvolupament de malalties humanes. En aquest sentit, hem identificat un grup de miRNAs amb una expressió alterada en l’òs osteoporòtic i hem demostrat la implicació funcional d’algun d’aquests miRNAs en la regulació de la formació òssia i els mecanismes pels quals es produiria l’osteoporosi. Alhora, també hem ofert una visió general dels miRNAs presents en el teixit ossi humà i en les cèl·lules òssies. També hem identificat variants genètiques dins de les seqüències de miRNAs expressats en osteoblasts, que han estat associades amb la densitat mineral òssia. A més a més, aquesta associació ha estat funcionalment demostrada en òs i osteoblasts. Aquest treball reflexa l’elevada complexitat que hi ha darrera del sistema regulador per miRNAs i obre nous camins per la recerca i la teràpia.
Tan, Boon-Kiang. "Non-invasive determinants of osteoporotic fracture risk." University of Western Australia. Centre for Musculoskeletal Studies, 2005. http://theses.library.uwa.edu.au/adt-WU2005.0125.
Повний текст джерелаTavares, Bruna Filipa Gonçalves. "Prevenção da osteoporose." Master's thesis, Universidade da Beira Interior, 2013. http://hdl.handle.net/10400.6/1408.
Повний текст джерелаIntroduction: The prevention of osteoporotic fractures involves the identification of the individuals with clinical risk factors for fracture, judicious performing of dual-energy x-ray absorptiometry (DXA), anti-osteoporotic treatment and patients’ follow-up. Created in 2008, validated for Portugal in 2012, the FRAX® tool (WHO Fracture Risk Assessment Tool) gives the 10-year probability of hip and major fracture, integrating multiple risk factors. The National Osteoporosis Foundation (NOF) determined two thresholds of high risk, ≥ 3% and ≥ 20% respectively, which indicates the treatment intervention of the OP, in USA. The adequacy of these thresholds has been the object of studies by other authors, but there aren’t any studies regarding the portuguese population. The main objective of this study was to determine the risk threshold, calculated using the FRAX® tool, which allows high sensitivity to identify individuals at high risk of hip fracture, in Portugal. Methods: From August to November 2012, a questionnaire and data collection from clinical process were performed to patients at least 50 years old, with nontraumatic hip fracture, admitted to the Orthopedics Service in Hospital Pêro da Covilhã, Hospital Sousa Martins and Hospital Amato Lusitano. The risk of hip fracture and the one of major fracture were calculated for each patient using the clinical FRAX® (without bone mineral density - BMD) measured for the Portuguese population. We analyzed the thresholds for risk FRAX® corresponding to a sensitivity of 95% and 80% for the incident hip fracture. Results: There were included 138 patients with non-traumatic hip fracture. The mean age was 83.5± 7.4 years (81.2% women). The most prevalent risk factors were: female gender, age over 65 years old, personal and parental history of fragility fracture and causes of secondary OP. 91.2% of patients had never performed DXA and 89.8% hadn’t previously made anti-osteoporotic treatment. The thresholds for high risk of hip fracture, by clinical FRAX®, with a sensitivity of 80% and 95% for the incident hip fracture were ≥5,5% and ≥3%, respectively. Conclusions: We identified appropriate thresholds at high risk for osteoporotic hip fracture, using FRAX® tool in the Portuguese population. These have an important application in clinical practice, as it allows a better identification of individuals at risk for careful selection of those who should perform DEXA and pharmacological treatment.
Castillón, Bernal Pablo. "Implementación de una unidad de trauma geriátrico." Doctoral thesis, Universitat Autònoma de Barcelona, 2020. http://hdl.handle.net/10803/670446.
Повний текст джерелаIntroducción En el año 1990 se produjeron 1,6 millones de fracturas de cadera en todo el mundo y se estima que esa cifra aumentará a 6 millones en el año 2050. En la Unión Europea se producen 600.000 fracturas de cadera al año, aproximadamente, con un coste global anual de 13.000 millones de Euros. La incidencia en España es de 517 casos por cada 100.000 habitantes y por año. La edad media de 82 años y un 78% de los pacientes son de sexo femenino. Los objetivos del tratamiento de la fractura de cadera son preservar la vida y conseguir una recuperación funcional que permita al paciente integrarse de nuevo en su medio habitual. Pero, en estos pacientes, la tasa de mortalidad se eleva durante el primer año de un 8,4% a un 36%. Al año de la fractura el 50% presentan dificultades para caminar, el 38-39% presentan dificultades para realizar transferencias y el 17-19% presentan dificultades para el aseo. Hasta un 90% de los pacientes presentan múltiples comorbilidades, entre las que la enfermedad pulmonar obstructiva crónica, la demencia, la hipertensión arterial, la patología cardiaca isquémica y la diabetes son las más comunes. Las características de estos pacientes, ancianos y con múltiples comorbilidades, hizo surgir la idea de proporcionarles una atención compartida entre cirujanos ortopédicos y geriatras. Esa idea inicial ha evolucionado a la tendencia actual de implementar unidades de ortogeriatría que integren un tratamiento multidisciplinar. En este modelo a geriatras y traumatólogos se suman también anestesistas, rehabilitadores, fisioterapeutas, enfermeras y nutricionistas, entre otros. Objetivos El objetivo principal de esta tesis doctoral es determinar la demora para intervención quirúrgica de los pacientes con fractura de fémur proximal tras la implementación de una unidad de ortogeriatría. Los objetivos secundarios son determinar el tiempo de estancia hospitalaria, la mortalidad intrahospitalaria y a los 30 días, y los reingresos que se producen por complicaciones médicas y traumatológicas. Material y métodos Durante el año 2013 (Junio-Diciembre), 2014 y 2015, ingresaron en nuestro servicio 534 fracturas de cadera, de forma consecutiva. Mientras que en los años 2011, 2012 y 2013 (Enero-Mayo), cuando todavía no existía la Unidad de Traumatología Geriátrica (UTG) ingresaron 501. Los datos recogidos prospectivamente en el segundo periodo, tras la implementación de la UTG, han sido comparados con los datos de los pacientes que ingresaron en el primer periodo. Resultados La demora media para ser intervenido quirúrgicamente previamente a la implementación de la UTG fue de 2,27 días (DE=2,35), mientras que posteriormente fue de 1,84 (DE=1,73). (p=0,0004). La estancia media previamente a la implementación de la UTG fue de 11,39 días (DE=9,05), mientras que posteriormente fue de 10,08 (DE=5,43). (p=0,0024). La mortalidad en los primeros 30 días tras la fractura de cadera, previamente a la implementación de la UTG fue del 7,7%, mientras que posteriormente fue del 4,8%. (p = 0,027). Conclusión La implementación de una unidad de ortogeriatría, para el tratamiento de los pacientes con fractura de fémur proximal, que incluye un conjunto de medidas entre las que destacan la introducción de circuitos rápidos de tratamiento, tratamiento multidisciplinar integrado y protocolos de rehabilitación temprana postoperatoria, ha permitido disminuir de 2,27 a 1,84 días el tiempo de demora medio para ser intervenido quirúrgicamente tras el ingreso. El tiempo de estancia hospitalaria se ha reducido en un tiempo medio de un día. La mortalidad de los pacientes a los 30 días se ha reducido en un 2,9%. Los reingresos por complicaciones médicas o quirúrgicas no se han incrementado.
Introduction In 1990, there were 1.6 million hip fractures worldwide. This number is expected to reach 6 million by 2050. In the European Union, osteoporosis causes approximately 600.000 hip fractures per year. The annual estimated economic burden for healthcare systems is 13.000 million Euros. The incidence of hip fractures in Spain is 517 cases per 100.000 inhabitants and year. The average age is 82 years and 78% are women. The goal of hip fracture treatment is to return the patient to preoperative levels of function, facilitating return to pre-fracture residence and supporting long-term wellbeing. Mortality rates in hip fracture patients rise from 8.4 to 36% in the first year after surgery. One year after the fracture, 50% have difficulties in walking, 38-39% are not able to transfer from a bed to a chair and 17-19% require aids for bathing and grooming. Up to 90% of patients have several comorbidities. Commonly, these include chronic obstructive pulmonary disease, dementia, high blood pressure, ischemic heart disease, and diabetes. Elderly patients with several comorbidities could benefit from shared care approaches provided by orthopedic surgeons and geriatricians. This cooperation has triggered the current trend of implementing orthogeriatric units that integrate multidisciplinary teams. In this model, several disciplines, besides surgeons and geriatricians, are involved in the care of the patients including anesthesiologists, physical therapists, nurses, and nutritionists. Objectives The main objective of this study is to determine the delay for surgical intervention of patients with proximal femur fracture after the implementation of an orthogeriatric unit. Secondary objectives are to determine the length of hospital stay, in-hospital and 30-day mortality, and readmissions resulting from medical and trauma complications. Material and methods During 2013 (June-December), 2014, and 2015, 534 consecutive hip fractures were treated in our hospital. While in 2011, 2012, and 2013 (January-May), before the orthogeriatric unit (OGU) was created, 501 hip fractures were treated. Data collected prospectively in the second period, after the implementation of the OGU, have been compared with the first period data. Results The mean delay to undergo surgery before the implementation of the OGU was 2.27 days (SD = 2.35), compared to 1.84 (SD = 1.73). (p = 0.0004) for the second period. The average in-hospital stay before the implementation of the OGU was 11.39 days (SD = 9.05), compared to 10.08 (SD = 5.43). (p = 0.0024) after the orthogeriatric model of care was established. 30-day mortality rate after hip fracture, before OGU implementation, was 7.7%, and 4.8% afterward. (p = 0.027). Conclusion The implementation of an orthogeriatric unit for the treatment of patients with a hip fracture which requires a series of measures including the introduction of fast treatment circuits, integrated multidisciplinary treatment, and early postoperative rehabilitation protocols, has allowed a decrease from 2.27 to 1.84 days in the average time to surgery after admission. The length of hospital stay was reduced by an average time of one day. 30-day mortality was reduced by 2.9%. Readmissions for medical or surgical complications did not increase.
Misra, Devyani. "Warfarin use and risk of osteoporotic fractures." Thesis, Boston University, 2012. https://hdl.handle.net/2144/21219.
Повний текст джерелаOBJECTIVE: Prior studies examining the association of warfarin use and osteoporotic fractures have found conflicting results and have had methodological problems, such as confounding by indication and confounding by duration of warfarin use. Thus, we studied the association of warfarin use with fractures at the hip, spine and wrist, among older men and women with atrial fibrillation recruited from the general population, using rigorous statistical tools to overcome challenges faced by prior studies. METHODS: We included men and women ≥65 years with incident atrial fibrillation, without history of fracture, followed between 2000-2010 from The Health Improvement Network (THIN). Long-term warfarin use was defined in two ways: 1) warfarin use ≥ 1year; 2) warfarin use ≥3 years. Non-use was defined as no use of warfarin over the follow-up period. Propensity scores (PS) for warfarin use were calculated using logistic regression with long-term use of warfarin as the dependent variable and age, sex, body mass index (BMI), history of multiple falls, deep venous thrombosis, pulmonary embolism, heart failure, neuropsychiatric impairment, hyperthyroidism, estrogen use, beta blockers, corticosteroids, bisphosphonates, smoking and alcoholism as independent variables. Each warfarin user was then matched by PS to a non-user by the “greedy matching” method. Incidence rates were calculated for warfarin users and non-users. The association between long-term warfarin use and risk of hip, spine and wrist fractures was evaluated using Cox-proportional hazards models. RESULTS: Incidence rates of hip fracture were 5.21 and 6.20 per 1000 person-years among subjects with warfarin use >1 (n=20,346) and >3 (n=11,238) years, respectively. The hazard ratios of hip fracture for warfarin use >1 and >3 years were 1.08 (95% CI 0.87, 1.35) and 1.13 (95% CI: 0.84, 1.5), respectively. Similar findings were observed between warfarin use and risk of spine or wrist fracture. CONCLUSIONS: Long-term use of warfarin among older adults with atrial fibrillation is not associated with increased risk of osteoporotic fractures and thus, does not necessitate additional surveillance or prophylaxis.
2031-01-01
Hillier, Sharon Lee. "Water fluoridation and osteoporotic hip fracture." Thesis, University of Southampton, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264665.
Повний текст джерелаBorgström, Fredrik. "Health economics of osteoporosis /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-781-2/.
Повний текст джерелаGuedj, Emmanuel. "Les fractures du sacrum par insuffisance osseuse." Montpellier 1, 1995. http://www.theses.fr/1995MON11050.
Повний текст джерелаКниги з теми "Osteoporosic fractures"
name, No. Vertebral osteoporotic compression fractures. Philadelphia, PA: Lippincott Williams & Wilkins, 2002.
Знайти повний текст джерелаGenant, Harry K. Vertebral fracture in osteoporosis. Edited by Jergas Michael and Van Kuijk Cornelis. San Francisco, Calif: University of California, San Francisco, 1995.
Знайти повний текст джерелаObrant, Karl, ed. Management of Fractures in Severely Osteoporotic Bone. London: Springer London, 2000. http://dx.doi.org/10.1007/978-1-4471-3825-9.
Повний текст джерелаGriffin, Jane. Osteoporosis and the risk of fracture. London: Office of Health Economics, 1990.
Знайти повний текст джерелаTakahashi, Hideaki E., David B. Burr, and Noriaki Yamamoto, eds. Osteoporotic Fracture and Systemic Skeletal Disorders. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-5613-2.
Повний текст джерелаRazi, Afshin E., and Stuart H. Hershman, eds. Vertebral Compression Fractures in Osteoporotic and Pathologic Bone. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-33861-9.
Повний текст джерелаSinaki, Mehrsheed. Non-Pharmacological Management of Osteoporosis: Exercise, Nutrition, Fall and Fracture Prevention. Cham: Springer International Publishing, 2017.
Знайти повний текст джерелаRinge, Johann. Osteoporotic fractures in the elderly: Clinical management and prevention. Stuttgart: Georg Thieme Verlag, 1996.
Знайти повний текст джерелаVereniging, Osteoporose, ed. Osteoporose: Patiëntenrichtlijn osteoporose en het voorkomen van botbreuken. 3rd ed. [Amsterdam]: Stichting September, 2011.
Знайти повний текст джерелаWendlova, Jaroslava. Biomechanical variables in assessment of fracture risk. Hauppauge, N.Y: Nova Science, 2011.
Знайти повний текст джерелаЧастини книг з теми "Osteoporosic fractures"
Bartl, Reiner, and Bertha Frisch. "Osteoporotic Fractures." In Osteoporosis, 165–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-79527-8_23.
Повний текст джерелаVialle, Luiz R., and Emiliano N. Vialle. "Osteoporotic Fractures." In Essentials of Spine Surgery, 61–68. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-80356-8_10.
Повний текст джерелаBartl, Reiner, and Bertha Frisch. "Risk Factors for Fractures." In Osteoporosis, 45–54. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-79527-8_5.
Повний текст джерелаHamdy, Ronald C. "Fracture Risk Assessment." In Osteoporosis, 46–61. Chichester, UK: John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118316290.ch4.
Повний текст джерелаMarques, Andréa Ascenção. "Osteoporosis and Fractures." In Perspectives in Nursing Management and Care for Older Adults, 65–78. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-18012-6_5.
Повний текст джерелаLasanianos, Nick G., George K. Triantafyllopoulos, and Spiros G. Pneumaticos. "Osteoporotic Vertebral Fractures." In Trauma and Orthopaedic Classifications, 251–54. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6572-9_56.
Повний текст джерелаMaes, Menno. "Osteoporosis — Insufficiency Fractures." In Spinal Imaging, 235–53. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-68483-1_10.
Повний текст джерелаTosounidis, Theodoros H., and Michael G. Kontakis. "Osteoporotic ankle fractures." In Surgical and Medical Treatment of Osteoporosis, 261–66. Boca Raton : CRC Press, [2020]: CRC Press, 2020. http://dx.doi.org/10.1201/9780429161087-27.
Повний текст джерелаOng, Terence, and Opinder Sahota. "Osteoporotic thoracolumbar fractures." In Surgical and Medical Treatment of Osteoporosis, 305–14. Boca Raton : CRC Press, [2020]: CRC Press, 2020. http://dx.doi.org/10.1201/9780429161087-31.
Повний текст джерелаTelera, Stefano, Laura Raus, Valerio Pipola, Federico De Iure, and Alessandro Gasbarrini. "Osteoporotic Vertebral Fractures." In Vertebral Body Augmentation, Vertebroplasty and Kyphoplasty in Spine Surgery, 133–48. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-76555-2_9.
Повний текст джерелаТези доповідей конференцій з теми "Osteoporosic fractures"
Kasra, Mehran, Marc D. Grynpas, Rajka Soric, and Sara Arnaud. "A Clinical Evaluation of Vibration Testing in the Assessment of Osteoporosis." In ASME 2000 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2000. http://dx.doi.org/10.1115/imece2000-2587.
Повний текст джерелаHiggins, Kathryn B., Robert D. Harten, Noshir A. Langrana, and Alberto M. Cuitino. "Biomechanics of Vertebroplasty." In ASME 2002 International Mechanical Engineering Congress and Exposition. ASMEDC, 2002. http://dx.doi.org/10.1115/imece2002-32635.
Повний текст джерелаFerreri, Suzanne, and Yi-Xian Qin. "Dynamic Mechanical Signals Delivered by Ultrasound Generate Site Specific Mediation of Bone Loss." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206219.
Повний текст джерела"An Informative Machine-Learning Tool for Diagnosis of Osteoporosis using Routine Femoral Neck Radiographs." In InSITE 2019: Informing Science + IT Education Conferences: Jerusalem. Informing Science Institute, 2019. http://dx.doi.org/10.28945/4350.
Повний текст джерелаSalas, Christina, Meir Marmor, Thomas Chu, Paul Hansma, Amir Matityahu, and Jenni M. Buckley. "Assessment of Local Bone Quality of the Distal Radius Using a Novel Hard Tissue Diagnostic Instrument." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-206823.
Повний текст джерелаTawackoli, Wafa, Gemunu Gunaratne, Fazle Hussain, and Michael Liebschner. "Dynamic Response of Normal and Osteoporotic Trabecular Bone by Vibration Analysis." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-81982.
Повний текст джерелаUral, Ani. "Evaluation of Fracture Load in Human Radius via Cohesive Finite Element Modeling." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-204316.
Повний текст джерелаNatella, LL, N. Bronsard, J. Allia, L. Hekayem, L. Euller-Ziegler, F. De Peretti, and V. Breuil. "FRI0578 Odontoid fractures in the elderly: an unknown osteoporotic fracture?" In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3503.
Повний текст джерелаM Benneker, Lorin. "Osteoporotic Spine Fractures." In eccElearning Postgraduate Diploma in Spine Surgery. eccElearning, 2017. http://dx.doi.org/10.28962/01.3.122.
Повний текст джерелаArdatov, Oleg, Vladimir Barsukov, and Dmitriy Karev. "Stress analysis of osteoporotic femur." In Biomdlore. VGTU Technika, 2016. http://dx.doi.org/10.3846/biomdlore.2016.10.
Повний текст джерелаЗвіти організацій з теми "Osteoporosic fractures"
Xiang, Kemeng, Huiming Hou, and Ming Zhou. The efficacy of Cerus and Cucumis Polypeptide injection combined with Bisphosphonates on postmenopausal women with osteoporosis:A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0067.
Повний текст джерелаMao, wei, Ai-guo LI, Fei DONG, Sheng Nan QIN, Pei liang he, guowei huang, and huan chen. Risk factors for secondary fractures to percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0128.
Повний текст джерелаYokota, Hiroki. Development of a Novel Synthetic Drug for Osteoporosis and Fracture Healing. Fort Belvoir, VA: Defense Technical Information Center, September 2014. http://dx.doi.org/10.21236/ada613289.
Повний текст джерелаYokota, Hiroki. Development of a Novel Synthetic Drug for Osteoporosis and Fracture Healing. Fort Belvoir, VA: Defense Technical Information Center, September 2012. http://dx.doi.org/10.21236/ada570122.
Повний текст джерелаDong, Depeng, Jiajun Huang, Dongxiang Chen, Liang Li, Zhiyong Huang, Dawei Luo, and Wenhui Zhang. Kiva augmentation technique versus balloon kyphoplasty for Osteoporotic vertebral compression fracture. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0068.
Повний текст джерелаFeng, Ningning, Jianbin Guan, Xing Yu, Wenhao Li, Tao Liu, Guozheng Jiang, Kaitan Yang, Yongdong Yang, and He Zhao. Jintiange Capsule May Have a Positive Effect in OVCF Patients with percutaneous vertebral augmentation: A Meta-Analysis of Randomized Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0038.
Повний текст джерелаFink, Howard A., Roderick MacDonald, Mary L. Forte, Christina E. Rosebush, Kristine E. Ensrud, John T. Schousboe, Victoria A. Nelson, et al. Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), April 2019. http://dx.doi.org/10.23970/ahrqepccer218.
Повний текст джерелаWang, Qiang, Changtai Sun, Liang Zhang, Lin Wang, Quan Ji, Nan Min, and Zilong Yin. High- Vs Low-Viscosity Cement Vertebroplasty For Osteoporotic Vertebral Compression Fracture: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2021. http://dx.doi.org/10.37766/inplasy2021.6.0110.
Повний текст джерелаLi, Tong, Yiran Wang, Qiang Ran, Yang Yu, Leiming Jiang, Yin Shi, Qun Zhou, and Xiaohong Fan. Unilateral curved percutaneous vertebroplasty for osteoporotic vertebral compression fractures: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0001.
Повний текст джерелаSun, Hai-Bo, Jian-Lin Shan, and Hai Tang. Percutaneous Vertebral Augmentation for Osteoporotic Vertebral Compression Fractures Will Increase the Number of Subsequent Fractures at Adjacent Vertebral Levels: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2021. http://dx.doi.org/10.37766/inplasy2021.5.0097.
Повний текст джерела